-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$27.0076.36% Upside
Icosavax, Inc. Frequently Asked Questions
-
What analysts cover Icosavax, Inc.?
Icosavax, Inc. has been rated by research analysts at Oppenheimer in the past 90 days.